| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/29/1997 | EP0813419A1 Modulators of regulatory proteins |
| 12/29/1997 | EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 12/29/1997 | EP0546096B1 Macrophage activating factor from vitamin d binding protein |
| 12/24/1997 | WO1997048807A1 CHEMOKINE β-15 |
| 12/24/1997 | WO1997048801A2 Polynucleotides encoding secreted proteins |
| 12/24/1997 | WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/24/1997 | WO1997048697A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 12/24/1997 | WO1997048696A1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 12/24/1997 | WO1997048695A1 New pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 12/24/1997 | WO1997048693A1 Isocoumarin derivatives and use thereof in drugs |
| 12/24/1997 | WO1997048691A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 12/24/1997 | WO1997048418A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 12/24/1997 | WO1997048410A1 Cyclosporin-containing soft capsule preparations |
| 12/24/1997 | WO1997048370A2 Vaccines comprising synthetic genes |
| 12/24/1997 | WO1997048368A2 Naphthyridines which affect il-4 and g-csf |
| 12/24/1997 | WO1997041230A3 Cc-type chemokines |
| 12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
| 12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |
| 12/24/1997 | WO1997025333A3 Macrocyclic compounds made from suboxide units |
| 12/24/1997 | CN1168697A Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 12/24/1997 | CN1168695A Inhibitor of stem cell proliferation and uses thereof |
| 12/24/1997 | CN1168679A Monoclonal antibody fragments having immunosuppressant activity |
| 12/24/1997 | CN1168677A Novel peptides derived from autoantigent for use in immunotherapy of autoimmune diseases |
| 12/24/1997 | CN1168667A Pyridopyrimidones, quinolines and fused N-heretocycles as bradykinin antagonists |
| 12/24/1997 | CN1168633A Boronic ester and acid compounds, synthesis and uses |
| 12/24/1997 | CA2258568A1 Vaccines comprising synthetic genes |
| 12/24/1997 | CA2258515A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 12/24/1997 | CA2258507A1 Chemokine beta-15 |
| 12/24/1997 | CA2257847A1 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/24/1997 | CA2257834A1 Polynucleotides encoding secreted proteins |
| 12/23/1997 | US5700907 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 12/23/1997 | US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 12/23/1997 | US5700791 Vitamin D derivatives modified in the 20-position and pharmaceutical compositions thereof |
| 12/23/1997 | US5700788 Treatment of hiv |
| 12/23/1997 | US5700787 Capsular polysaccharide immunomodulator |
| 12/23/1997 | US5700664 For pharmaceutical preparations for stimulating cells involved in immune response and proper functioning of hematopoietioc system |
| 12/23/1997 | CA2126972C Styrene derivative and salts thereof |
| 12/18/1997 | WO1997047744A2 T-cell selective interleukin-4 agonists |
| 12/18/1997 | WO1997047659A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides |
| 12/18/1997 | WO1997047644A1 T cell antigen receptor peptides |
| 12/18/1997 | WO1997047618A1 Substituted imidazoles having cytokine inhibitory activity |
| 12/18/1997 | WO1997047604A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same |
| 12/18/1997 | WO1997047358A1 Synthetic hepatitis c genes |
| 12/18/1997 | WO1997035982A3 Monocyte chemotactic protein-5 materials and methods |
| 12/18/1997 | WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 12/18/1997 | CA2257137A1 Synthetic hepatitis c genes |
| 12/18/1997 | CA2256459A1 T-cell selective interleukin-4 agonists |
| 12/17/1997 | EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family |
| 12/17/1997 | EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists |
| 12/17/1997 | EP0812593A1 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a |
| 12/17/1997 | EP0812588A1 External preparation |
| 12/17/1997 | EP0812362A1 A plasmid for expressing modified recombinant proteins in a bacterial system |
| 12/17/1997 | EP0812330A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 12/17/1997 | EP0812209A1 Cochleate phospholipids in drug delivery |
| 12/17/1997 | EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 12/17/1997 | EP0812206A1 Method for stimulating an immune response |
| 12/17/1997 | EP0812195A1 Pharmaceutical composition for piperidinoalkanol compounds |
| 12/17/1997 | EP0812194A1 Method for treating atopic dermatitis and contact dermatitis |
| 12/17/1997 | EP0656789B1 Method for treating a lfa-1-mediated disorder |
| 12/17/1997 | EP0652896B1 Peptide compounds |
| 12/17/1997 | EP0651743B1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
| 12/17/1997 | EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 12/17/1997 | EP0540599B1 Adoptive immunotherapy with interleukin-7 |
| 12/17/1997 | CN1168138A Aryl and heteroaryl purine compounds |
| 12/17/1997 | CN1167777A Interferon conjugates |
| 12/17/1997 | CN1167617A Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 12/16/1997 | US5698706 Heterocyclic amides and methods of use |
| 12/16/1997 | US5698690 Hydroxamic acid derivatives with tricyclic substitution |
| 12/16/1997 | US5698679 Immunoglobulin fusion protein |
| 12/16/1997 | US5698558 Methods for treating allergic disorders using optically pure (-) cetirizine |
| 12/16/1997 | US5698552 Hetrazepinoid amides |
| 12/16/1997 | US5698520 Peptide related to human programmed cell death and DNA encoding the same |
| 12/16/1997 | US5698445 Human PAK65 |
| 12/16/1997 | US5698428 Human PAK65 |
| 12/16/1997 | US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies |
| 12/16/1997 | US5698204 Polypeptides |
| 12/16/1997 | US5698203 Attenuated viruse reactive with monoclonal antibody a27 |
| 12/16/1997 | US5698194 Method for making a medicament for treating secondary immunodeficiency |
| 12/16/1997 | CA2086432C 3-(1-substitutedpyrazoyl)-2-oxindole derivatives |
| 12/11/1997 | WO1997046685A1 Polynucleotides encoding secreted proteins from human dendritic cells |
| 12/11/1997 | WO1997046683A2 Polynucleotides encoding secreted proteins |
| 12/11/1997 | WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins |
| 12/11/1997 | WO1997046671A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | WO1997046578A1 Peptide derivatives |
| 12/11/1997 | WO1997046524A1 Novel pyrrole derivatives |
| 12/11/1997 | WO1997046522A1 Novel vitamin d analogues |
| 12/11/1997 | WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| 12/11/1997 | WO1997046251A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 12/11/1997 | WO1997046245A1 Pharmaceutical composition which is stable during storage and contains a thymus extract |
| 12/11/1997 | WO1997046243A1 A nasal spray containing an intranasal steroid and an antihistamine |
| 12/11/1997 | WO1997046206A2 Human thyrotropin receptor compositions and use thereof |
| 12/11/1997 | WO1997040017A3 Modulators of molecules with phosphotyrosine recognition units |
| 12/11/1997 | DE19622422A1 Lagerungsstabile pharmazeutische Zusammensetzung mit immun - modulierenden und antiinflammatorischen Eigenschaften sowie ein Verfahren zu dessen Herstellung Storage stable pharmaceutical composition having immuno - modulatory and anti-inflammatory properties and a process for its preparation |
| 12/11/1997 | CA2258720A1 Human thyrotropin receptor compositions and use thereof |
| 12/11/1997 | CA2256721A1 A nasal spray containing an intranasal steroid and an antihistamine |
| 12/11/1997 | CA2256522A1 Polynucleotides encoding secreted proteins |
| 12/11/1997 | CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells |
| 12/11/1997 | CA2256456A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | CA2256449A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies |
| 12/11/1997 | CA2252417A1 Peptide derivatives |